PROTEINURIA REDUCTION WITH SPARSENTAN IN IMMUNOGLOBULIN A NEPHROPATHY (IGAN): PROTECT STUDY INTERIM RESULTS

被引：0
|
作者：
Radhakrishnan, Jai [1 ]
Wong, Muh Geot [2 ,3 ]
Heerspink, Hiddo J. L. [4 ]
Komers, Radko [5 ]
Prasad, Andy [5 ]
Mercer, Alex [6 ]
机构：
[1] Columbia Univ, New York, NY USA
[2] Concord Repatriat Gen Hosp, Concord, NSW, Australia
[3] Univ Sydney, Concord Clin Sch, Camperdown, NSW, Australia
[4] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands
[5] Travere Therapeut Inc, San Diego, CA USA
[6] JAMCO Pharma Consulting, Stockholm, Sweden
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2023年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
329
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [21] ATRASENTAN FOR THE TREATMENT OF IGA NEPHROPATHY: INTERIM RESULTS FROM THE AFFINITY STUDY
    Kim, Sung-Gyun
    Nam Vo
    Lee, Sang-Ho
    Ranganathan, Dwarakanathan
    Inker, Lesley
    El-Shahawy, Mohamed
    Spinelli, Terri
    Sheth, Khushboo
    Devries, Todd
    Camargo, Marianne
    King, Andrew
    Glicklich, Alan
    Wong, Muh
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I816 - I817
  • [22] TARGET POPULATION ESTIMATES USING REAL WORLD EVIDENCE (RWE) IN RARE DISEASES: A CASE STUDY IN IMMUNOGLOBULIN A NEPHROPATHY (IGAN)
    Kwon, C.
    Daniele, P.
    Forsythe, A.
    Ngai, C.
    [J]. VALUE IN HEALTH, 2021, 24 : S236 - S236
  • [23] PROTECT interim results: A large multicenter study of patients with type II diabetes
    Baron, A
    Neumann, C
    [J]. CLINICAL THERAPEUTICS, 1997, 19 (02) : 282 - 295
  • [24] The Effect of Hydroxychloroquine on Residual Proteinuria in Patients With Immunoglobulin A Nephropathy: A Retrospective Study Based on Propensity Score Matching
    Liu, Mijia
    Bian, Xueyan
    Wang, Li
    Li, Guisen
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [25] PROTEINURIA REDUCTION IN IGA NEPHROPATHY BY NEFECON, A TARGETED RELEASE FORMULATION OF BUDESONIDE - RESULTS FROM THE NEFIGAN TRIAL
    Fellstrom, Bengt
    Barratt, Jonathan
    Cook, Heather
    Coppo, Rosanna
    Feehally, John
    defijter, Johan
    Floege, Jurgen
    Hetzel, Gerd
    Jardine, Alan
    Locatelli, Francesco
    Maes, Bart
    Mercer, Alex
    Ortiz, Fernanda
    Praga, Manuel
    Sorensen, Soren
    Tesar, Vladimir
    DelVecchio, Lucia
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 82 - +
  • [26] A RETROSPECTIVE COHORT STUDY OF BIOPSY-PROVEN IMMUNOGLOBULIN A NEPHROPATHY (IGAN) IN AUCKLAND AND NORTHLAND-INCIDENCE, CLINICAL FEATURES, THERAPIES, AND OUTCOMES
    Richards, Alastair
    De Zoysa, Janak
    [J]. NEPHROLOGY, 2022, 27 : 82 - 83
  • [27] An Interim Analysis of Clinical and Histopathological Results of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study
    Mohandes, Samer
    Abedini, Amin
    Al-Obaidi, Mustafa
    Devalaraja-Narashimha, Kishor B.
    Morton, Lori
    Liles, John T.
    Hu, Erding
    Sarov-Blat, Lea
    Kalra, Gurmannat
    Guarnieri, Paolo
    Karihaloo, Anil K.
    Palmer, Matthew
    Susztak, Katalin
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 119 - 119
  • [28] Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
    Rovin, Brad H.
    Barratt, Jonathan
    Heerspink, Hiddo J. L.
    Alpers, Charles E.
    Bieler, Stewart
    Chae, Dong-Wan
    Diva, Ulysses A.
    Floege, Juergen
    Gesualdo, Loreto
    Inrig, Jula K.
    Kohan, Donald E.
    Komers, Radko
    Kooienga, Laura Ann
    Lafayette, Richard
    Maes, Bart
    Malecki, Robert
    Mercer, Alex
    Noronha, Irene L.
    Oh, Se Won
    Peh, Chen Au
    Praga, Manuel
    Preciado, Priscila
    Radhakrishnan, Jai
    Rheault, Michelle N.
    Rote, William E.
    Tang, Sydney C. W.
    Tesar, Vladimir
    Trachtman, Howard
    Trimarchi, Hernan
    Tumlin, James A.
    Wong, Muh Geot
    Perkovic, Vlado
    [J]. LANCET, 2023, 402 (10417): : 2077 - 2090
  • [29] A prospective, randomized, case-controlled study on the efficacy of mycophenolate mofetil (MMF) for IgA nephropathy (IgAN) patients with persistent proteinuria despite angiotensin blockade.
    Tang, S
    Leung, JCK
    Tang, AWC
    Ho, YW
    Chan, LYY
    Chan, TM
    Lai, KN
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 752A - 753A
  • [30] THE 24-WEEK INTERIM ANALYSIS RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II STUDY OF ATACICEPT IN PATIENTS WITH IGA NEPHROPATHY AND PERSISTENT PROTEINURIA
    Barratt, Jonathan
    Tumlin, James A.
    Suzuki, Yusuke
    Kao, Amy
    Aydemir, Aida
    Zima, Yulia
    Appel, Gerald
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 139 - 139
12345